[1] 吴启家, 黄林, 张翼. 催化RNA的结构与功能. 中国科学C辑: 生命科学, 2009, 39(1): 7890. Wu Q J, Huang L, Zhang Y. Science in China Press. 2009, 39(1): 7890.
[2]侯化, 金由辛. Ribozyme在基因治疗中的研究进展. 医学信息, 2000, 13(5): 265267. Hou H, Jin Y X. Medical Information, 2000, 13(5): 265267.
[3]侯丙凯, 于惠敏. Ribozyme在疾病治疗中的应用. 国外医学遗传学分册, 1995, 4: 202203. Hou B K, Yu H M. Foreign Medical Sciences, 1995, 4: 202203.
[4]Levon M Khachigian, Ravinay Bhindi, Roger G Fahmy, et al. DNA enzymes, short interfering RNA, and the emerging wave of smallmolecule nucleic acidbased genesilencing strategies. The American Journal of Pathology, 2007, 171(4): 10791088.
[5]Ronald T Mitsuyasu, Thomas C Merigan, Andrew Carr, et al.Phase 2 gene therapy trial of an antiHIV ribozyme in autologous CD34+ cells. Nature Medicine, 2009, 15(3): 285292.
[6]贾战生, 陈琳, 郝春秋. 丙型肝炎病毒锤头结构核酶的细胞内免疫. 世界华人消化杂志, 2003, 11(12): 148150 Jia Z S, Chen L, Hao C Q. World Chin J Digestol, 2003, 11(12): 148150.
[7] Michel V Le′vesque, Dominique Le′vesque, Francis P Brie`re, et al. Investigating a new generation of ribozymes in order to target HCV. PLoS ONE. 2010, 5(3): e9627.
[8] David C Bloom, Jia Liu, Alfred S Lewin, et al. Reduction in severity of a herpes simplex virus type 1 murine infection by treatment with a ribozyme targeting the UL20 gene RNA. J Virol, 2008, 82(15): 74677474.
[9] 李满文, 贺福初. BCR3/ABL2核酶的设计、构建及对K562细胞增殖与集落形成的抑制作用和凋亡诱导作用. 中国生物化学与分子生物学报, 2000, 16(1): 1016. Li M W, He F C. Chinese Journal of Biochemistry and Molecular Biology, 2000, 16(1): 1016.
[10] 张敏, 刘芳, 游泳, 等. 切割Fas mRNA核酶的构建及其体内外切割活性的鉴定. 中国生物化学与分子生物学报. 2004, 20(5): 643647. Zhang M, Liu F, You Y, et al. Chinese Journal of Biochemistry and Molecular Biology, 2004, 20(5): 643647.
[11] Carol A Kruse, Richard Tritz, Cellia Habita, et al. Catalytic nucleic acid enzymes for the study and development of therapies in the central nervous system: review article. Gene Ther Mol Biol, 2005, 9A: 89106.
[12] Levon M Khachigian. Catalytic DNAs as potential therapeutic agents and sequencespecific molecular tools to dissect biological function. Nucleic Acid Therapeutics, 2000, 106(10): 11891195.
[13] 刘芳, 邹萍, 吴耀辉, 等. 锤头状核酶对转化生长因子β1 RNA的体外剪切作用. 中国生物化学与分子生物学报, 2006, 22(1): 5962. Liu F, Zou P, Wu Y H, et al. Chinese Journal of Biochemistry and Molecular Biology, 2006, 22(1): 5962.
[14] 毛建平, 王全会, 韩慧明, 等. 1023型DNA酶作为鉴定mRNA靶点有效性的新工具. 中国生物化学与分子生物学报, 2005, 21(5):622627. Mao J P, Wang Q H, Han H M, et al. Chinese Journal of Biochemistry and Molecular,2005, 21(5):622627.
[15] 王全会, 左刚, 袁国刚, 等. 1023型脱氧核酶对mRNA表达的双重抑制作用. 军事医学科学院院刊, 2005, 29(6): 531534. Wang Q H, Zuo G, Yuan G G, et al. Bull Acad Mil Med Sci, 2005, 29(6): 531534.
[16] 刘其友, 张云波, 赵朝成, 等. 脱氧核酶的应用研究进展. 化学与生物工程, 2009, 26(8): 1215. Liu Q Y, Zhang Y B, Zhao C C, et al. Chemistry & Bioengineering, 2009, 26(8): 1215.
[17] 杨永光, 李明意, 赵家明, 等. 1023脱氧核酶沉默Survivin基因表达诱导人肝癌细胞的凋亡. 广东医学, 2009, 30(2): 185187. Yang Y G, Li M Y, Zhao J M, et al. Guangdong Medical Journal, 2009, 30(2): 185187.
[18] Elizabeth R Rayburn, Ruiwen Zhang.Antisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible?. Drug Discov Today, 2008, 13(1112): 513521. |